Market Overview
Biosimilar bevacizumab is a biological product highly like the reference biologic Avastin. It is used to treat various types of cancer, including colorectal, lung, breast, kidney, and ovarian cancer. The biosimilar market for bevacizumab has witnessed significant growth due to the increasing prevalence of cancer, the high cost of the reference product, and the growing acceptance...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian